SCHEMBL4937607

SCHEMBL4937607

COc1ccc(C2=NN(c3ccc(C(=O)N4CCOCC4)cc3)C(=O)C(C)(C)C2)cc1OC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.54
HPGD P15428 3/20 0.54
PKM P14618 2/20 0.54
POLB P06746 1/20 0.54
KMT2A Q03164 5/20 0.52
NPC1 O15118 1/20 0.50
CFTR P13569 1/20 0.48
GLA P06280 1/20 0.47
PRKCZ Q05513 1/20 0.46
MEN1 O00255 3/20 0.45
JAK2 O60674 1/20 0.45
ALDH1A1 P00352 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
MAPK1 P28482 1/20 0.44
APC P25054 1/20 0.44
PDE4B Q07343 3/20 0.43
KDM4E B2RXH2 1/20 0.43
HTT P42858 1/20 0.43
PDE4A P27815 1/20 0.43
PDE4C Q08493 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4945220 0.92 TLR9 (0.51) MAPTHPGDPKMPOLBKMT2A
SCHEMBL4944659 0.91 MAPT (0.48) MAPTHPGDPKMPOLBKMT2A
SCHEMBL4942500 0.88 MAPT (0.48) MAPTHPGDPKMKMT2ANPC1
SCHEMBL4943065 0.88 HTT (0.57) MAPTHPGDPKMKMT2ANPC1
Hydrochloric Acid SCHEMBL4937621 0.87 GAA (0.49) MAPTNPC1CFTRALDH1A1SMN1; SMN2
SCHEMBL4943419 0.86 TP53 (0.55) MAPTHPGDPOLBNPC1GLA
SCHEMBL4944690 0.84 PDE5A (0.53) KMT2AMEN1ALDH1A1PDE4BPDE4A
Hydrochloric Acid SCHEMBL4941529 0.83 F10 (0.47) HPGDKMT2ANPC1MEN1PDE4B
SCHEMBL4945670 0.82 PDE4B (0.51) PDE4BPDE4APDE4CPDE4D
SCHEMBL4940552 0.80 PDE4B (0.51) PDE4BPDE4APDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080227790-A1 Pyridazinone Derivatives and their Use as Pde4 Inhibitors ALTANA PHARMA AG (DE) 2008-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080227790-A1 Pyridazinone Derivatives and their Use as Pde4 Inhibitors PDE4A, PDE4B, PDE5A MAPT 4017/4885HPGD 287/4885PKM 248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.